Researchers have found a link between low testosterone levels and aggressive tumors, which could change how prostate cancer ...
Read more about how low testosterone levels are linked to ‘extreme’ disease progression in patients with prostate cancer under active surveillance.
Los Angeles, Calif. – Testosterone therapy does not cause adverse effects on the prostate in older men with hypogonadism, commonly known as low testosterone or low T, according to a clinical trial ...
This article was reviewed by Darragh O’Carroll, MD. PSA and Testosterone: Are They Linked? Prostate-specific antigen (PSA) is a term you’ll probably become familiar with once you start getting ...
USA: A retrospective cohort study has found that low testosterone levels in patients with prostate cancer undergoing active ...
MedPage Today on MSN
Low Testosterone May Raise Risk of 'Extreme' Prostate Cancer Progression
Results challenge view that high testosterone fuels prostate cancer growth ...
Testosterone testing and treatment have increased significantly over the past 2 decades, yet clinical practices remain inconsistent. 1,2 Despite rising awareness and prescription trends, up to 25% of ...
Although the Endocrine Society guidelines recommend TRT for men with testosterone levels ≤ 300 ng/dL in two morning samples, a primary concern is its potential to exacerbate prostate-related ...
SAN ANTONIO — A small pilot study delivered a big message about the use of testosterone in men with advanced or metastatic prostate cancer, according to a "Best Abstract" presented at the Sexual ...
This article was reviewed by Darragh O’Carroll, MD. Prostate-specific antigen (PSA) is a term you’ll probably become familiar with once you start getting screened regularly for prostate cancer ...
(HealthDay News) — Low testosterone levels may increase the risk of higher-grade “extreme” progression of prostate cancer among men enrolled in active surveillance (AS), according to a study published ...
The testosterone threshold should be less than 10 ng/dL rather than less than 50 ng/dL for gauging advanced prostate cancer prognosis in patients on ADT. Examining sustained testosterone suppression ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果